OIG Calls Upon CMS To Strengthen DMEPOS Fraud Prevention
Compliance Officers Recommended Actions
Durable Medical Equipment, Prosthetics, Orthotics, and Supplies (DMEPOS) fraud remains a costly challenge for Medicare, draining millions of taxpayer dollars each year. In an August 20, 2026, white paper titled “The Nation’s Challenge to Combat Durable Medical Equipment Fraud in Medicare,” the Office of Inspector General (OIG) warned that wrongdoers continue to exploit weaknesses in supplier enrollment, physician orders, and beneficiary identification numbers, costing taxpayers millions of dollars. The OIG identified familiar vulnerabilities: suppliers can be created, purchased, or concealed behind straw owners; physician orders can be forged, misused, or tied to kickback arrangements; and beneficiary data can be obtained through scams, cyberattacks, or misuse of lookup tools. The white paper presents actions for the Centers for Medicare & Medicaid Services to strengthen program integrity.
Key compliance risks include weak supplier vetting, hidden ownership, outdated bond requirements, forged or template-driven orders, stolen provider identifiers, kickbacks, misuse of Medicare numbers, and inadequate prepayment claims monitoring. For compliance officers, the message is clear: DMEPOS controls should be a priority for risk assessment, auditing, monitoring, and staff education before weaknesses become enforcement issues. Compliance officers should use the OIG report as a prompt to act now. Recommended actions include:
- Conduct a DMEPOS risk assessment addressing vulnerabilities in supplier enrollment, physician orders, and beneficiary data.
- Strengthen supplier due diligence by reviewing ownership changes, site-visit findings, bonds, exclusion-screening results, and patterns involving new or high-risk suppliers.
- Test order controls to confirm that documentation is valid, complete, medically necessary, and free of kickback or template-driven concerns.
- Tighten beneficiary-data safeguards by limiting access to lookup tools, monitoring unusual activity, and reinforcing controls against unsolicited marketing.
- Audit claims for suspicious billing patterns, duplicate submissions, abnormal utilization, and rapidly increasing supplier volume.
- Obtain an independent assessment of the compliance program to document progress and identify weaknesses and opportunities for improvement.
- Document corrective actions, including suspending high-risk suppliers, updating policies, retraining staff, tightening access controls, revising order-verification procedures, refunding overpayments, and conducting follow-up audits.
Interested in getting support for your compliance program? Connect with us to speak with a Compliance Healthcare Advisor.
